Skip to main content
Have a personal or library account? Click to login
Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways Cover

Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways

By: Mengxian Shu and  Chunhui Xiang  
Open Access
|Mar 2026

Authors

Mengxian Shu

Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Department of Pulmonology and Endocrinology, Enshi City, China

Chunhui Xiang

xch_dr@163.com

Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Department of Neurosurgery, Enshi City, China
DOI: https://doi.org/10.2478/aiht-2026-77-4026 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 21 - 27
Submitted on: Jul 1, 2025
Accepted on: Mar 1, 2026
Published on: Mar 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Mengxian Shu, Chunhui Xiang, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.